Glycemic Control and Excess Mortality in Type 1 Diabetes
Marcus Lind(University of Stirling), Annika Rosengren(Sahlgrenska University Hospital), Mark A. Clements(Children's Mercy Hospital), Sofia Dahlqvist(NU Hospital Group), Mikhail Kosiborod(AstraZeneca (Brazil)), Ann‐Marie Svensson(Region Västra Götaland), Soffia Guðbjörnsdóttir(University of Gothenburg), Aldina Pivodic, Hans Wedel(Sahlgrenska University Hospital)
Cited by 952
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
|The Lancet|1998|5.8k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
|New England Journal of Medicine|2007|4.6k
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
|New England Journal of Medicine|2004|4.5k